antepartum - Nursing Case Study

Pathophysiology

• Primary mechanism: Placental insufficiency - This occurs when the placenta does not function effectively, leading to inadequate supply of oxygen and nutrients to the fetus, potentially resulting in intrauterine growth restriction (IUGR) and hypoxia.

• Secondary mechanism: Hormonal imbalances - Conditions such as gestational diabetes and preeclampsia are influenced by hormonal changes during pregnancy, which can cause alterations in glucose metabolism and blood pressure regulation, posing risks to both mother and fetus.

• Key complication: Preterm labor - This can be triggered by infections, uterine overdistension, or stress, leading to contractions and cervical changes before 37 weeks of gestation, increasing risks of neonatal morbidity and mortality.

Patient Profile

Demographics:

32-year-old female, high school teacher

History:

• Key past medical history: Gestational diabetes in a previous pregnancy, hypertension

• Current medications: Prenatal vitamins, labetalol

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased fatigue and shortness of breath

• Key symptoms: Swelling in hands and feet, occasional headaches, dizziness

• Vital signs: Blood pressure 150/95 mmHg, heart rate 95 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F

Section 1

As the healthcare team conducts an initial assessment, the patient's condition raises concern due to several key findings. On physical examination, there is noticeable pitting edema in the lower extremities and persistent swelling in the hands and face, indicative of possible fluid retention related to preeclampsia. The patient reports increasingly frequent headaches and persistent dizziness, which, combined with her elevated blood pressure of 150/95 mmHg, suggests worsening hypertensive disorders in pregnancy. The fetal heart rate is monitored, showing a baseline of 170 beats per minute with occasional late decelerations, raising suspicion of fetal distress likely due to placental insufficiency.

Laboratory tests are promptly ordered to further evaluate the patient's condition. A urine dipstick test reveals 2+ proteinuria, supporting a diagnosis of preeclampsia. Serum lab results show elevated liver enzymes (AST 45 IU/L, ALT 50 IU/L) and a low platelet count (120,000/mm³), indicating a possible progression towards HELLP syndrome, a severe form of preeclampsia. Additionally, blood glucose levels are checked, revealing hyperglycemia at 140 mg/dL, suggesting poor control of gestational diabetes, which could exacerbate the current complications.

In response, the healthcare team initiates a more aggressive management plan to stabilize the patient and prevent further complications. Intravenous magnesium sulfate is administered to prevent eclamptic seizures, and the decision is made to deliver corticosteroids to enhance fetal lung maturity in anticipation of possible preterm delivery. The patient is closely monitored in a high-dependency unit, with frequent assessment of vital signs, fetal monitoring, and regular laboratory checks to evaluate the effectiveness of interventions and the need for possible escalation to delivery should maternal or fetal status deteriorate further. This proactive approach aims to mitigate risks and ensure both maternal and fetal safety as the team navigates the complexities of her clinical condition.

Section 2

As the healthcare team continues to monitor the patient closely, new diagnostic results reveal further complications. Repeat laboratory tests indicate a worsening of the patient's condition. The platelet count has decreased further to 100,000/mm³, and liver enzymes are now markedly elevated (AST 70 IU/L, ALT 85 IU/L), confirming the progression to HELLP syndrome. Additionally, the serum creatinine level has risen to 1.3 mg/dL, suggesting impaired renal function, likely due to the ongoing hypertensive crisis and preeclampsia. These findings necessitate an urgent reassessment of the management plan.

In response to the deteriorating lab results and the continued presence of severe symptoms such as persistent headaches and visual disturbances, the healthcare team intensifies the treatment regimen. The patient's blood pressure remains elevated, now at 160/100 mmHg, despite initial antihypertensive therapy, prompting the adjustment of her medication to include a combination of labetalol and hydralazine for better control. The fetal heart rate continues to show signs of distress, with recurrent late decelerations and a persistently elevated baseline, reinforcing the need for close fetal surveillance and the potential for emergency delivery.

The patient is informed of the critical nature of her condition and the possible need for expedited delivery to ensure the safety of both herself and her baby. The team discusses the risks and benefits of different delivery options, including the possibility of a cesarean section, given the likelihood of further deterioration and the current signs of fetal compromise. This decision-making process highlights the importance of timely intervention and the need for ongoing, dynamic clinical reasoning to adapt to the evolving clinical picture. As the patient's condition remains precarious, the healthcare team prepares for all potential scenarios, ensuring that resources are available for immediate response should an urgent delivery become necessary.

Section 3

As the healthcare team continues their intensive monitoring, new diagnostic results reveal further complications that warrant immediate attention. The patient's latest complete blood count shows a further drop in platelet count to 90,000/mm³, indicating a worsening of the thrombocytopenia associated with HELLP syndrome. The liver function tests also show continued deterioration, with AST levels now at 95 IU/L and ALT at 110 IU/L. These values suggest a significant hepatic strain and potential risk for liver rupture or hemorrhage, emphasizing the criticality of the situation. The renal function remains compromised, with serum creatinine creeping up to 1.5 mg/dL, signaling acute kidney injury in the context of severe preeclampsia.

Clinically, the patient reports increased abdominal pain localized to the right upper quadrant, a classic symptom of worsening HELLP syndrome. Her blood pressure, despite the adjusted antihypertensive regimen, remains concerning at 165/105 mmHg, and she continues to experience severe headaches and worsening visual disturbances. The fetal heart rate pattern demonstrates persistent late decelerations, correlating with the deteriorating maternal condition and underlining the need for immediate obstetric intervention.

In response to these alarming developments, the healthcare team convenes a multidisciplinary meeting to reassess the management strategy. The consensus is reached on the urgent need for delivery, prioritizing a cesarean section given the maternal and fetal indications. Preparations for surgery are expedited, with anesthesia, pediatric, and neonatal teams on standby. The aim is to stabilize the mother's condition and mitigate further risks to both her and the baby. The clinical reasoning underscores the dynamic nature of obstetric emergencies, where rapid decision-making and coordinated team action are paramount in managing the complex interplay of maternal and fetal health.

Section 4

As the patient is prepped for the cesarean section, the healthcare team performs a final preoperative assessment to ensure all parameters are stabilized as much as possible before surgery. The patient's blood pressure remains elevated at 170/110 mmHg despite the administration of intravenous labetalol, highlighting the severity of her hypertensive state. Her heart rate is noted at 105 beats per minute, with respiratory rate at 24 breaths per minute, indicating tachycardia and mild tachypnea. Her oxygen saturation is maintained at 96% on room air, but she continues to report shortness of breath and escalating anxiety, likely exacerbated by her critical condition.

Laboratory results obtained just before the operation reveal further deterioration in her hematological profile. Her platelet count has dropped to 80,000/mm³, increasing the risk of bleeding during surgery. Coagulation studies show a slightly prolonged prothrombin time (PT) and partial thromboplastin time (PTT), suggesting a coagulopathy developing alongside the thrombocytopenia. The liver function tests have worsened, with AST and ALT now elevated to 120 IU/L and 130 IU/L, respectively, intensifying concerns over potential liver compromise. The team's clinical reasoning emphasizes the need for meticulous hemostatic control during the cesarean to prevent excessive bleeding, alongside careful monitoring of the patient's hepatic function post-delivery.

As the team proceeds with the cesarean section, they are acutely aware of the need to deliver the baby swiftly to minimize fetal distress, evidenced by the persistent late decelerations on the fetal heart tracing. The neonatology team is prepared to provide immediate support to the newborn, anticipating potential complications such as respiratory distress or low birth weight associated with preterm delivery. The surgical team is also briefed on the necessity of rapid yet careful handling to mitigate the risks stemming from the maternal coagulopathy and compromised liver function. This phase of the patient's journey highlights the critical interplay of surgical expertise and vigilant postoperative care to stabilize both mother and child, setting the stage for the next steps in their recovery.

Section 5

As the cesarean section proceeds, the team encounters a new complication that requires immediate attention. Despite the preoperative administration of labetalol, the patient's blood pressure has further escalated to 180/115 mmHg during the surgery. Her heart rate has risen to 110 beats per minute, and her respiratory rate is now at 26 breaths per minute, indicating worsening tachycardia and tachypnea. Her oxygen saturation drops slightly to 94% on room air, further compounding her respiratory distress and anxiety. The anesthesiologist quickly adjusts the anesthesia plan, administering additional antihypertensive medication and providing supplemental oxygen to stabilize her vital signs.

Simultaneously, the surgical team notes increased bleeding from the incision site, consistent with the patient's earlier lab results indicating thrombocytopenia and coagulopathy. The decision is made to administer a platelet transfusion intraoperatively to address her low platelet count, aiming to improve clotting and reduce bleeding risk. The anesthesiology team begins the transfusion promptly, closely monitoring the patient's hemodynamic status and adjusting fluid management to maintain stability.

Post-delivery, the neonate exhibits initial respiratory distress, with an Apgar score of 6 at one minute. The neonatology team initiates supportive measures, including gentle positive pressure ventilation. Meanwhile, the mother is transferred to the recovery room for close observation. Her liver function tests are repeated, showing a slight improvement in AST and ALT levels, now at 110 IU/L and 120 IU/L, respectively, suggesting a cautious optimism for hepatic recovery. The healthcare team remains vigilant, understanding that the next 24 hours are critical for monitoring potential complications such as hemorrhage or further liver dysfunction, while the mother and newborn begin the recovery process.